How do you handle medication management for patients on immunosuppressive therapy who are lost to follow-up?
Do you continue infusions/medication refills for a set period of time even if the patient does not show for appointments? Does your management change if it is a more serious relapse-prone condition like MS or NMOSD?
Answer from: at Academic Institution
I typically require one clinical visit at least once a year at minimum to continue prescribing immunotherapy, with a grace period of a few months. If they are lost to follow-up, I cannot ensure safety or clinical efficacy, nor address symptoms or comorbid conditions that worsen their disease. Our te...